Heptaplatin T21307
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Heptaplatin, a new platinum derivative with anticancer activity, is used against various cancer cell lines, including cisplatin-resistant cancer cell lines. It has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in t
CAS nr:
146665-77-2
Purity:
98%
Molecular Weight:
471,37
SMILES:
[O-]C(CC([O-])=O)=O.NC[C@H]1OC(O[C@@H]1CN)C(C)C.[Pt+2]
Formula:
C11H20N2O6Pt
Pathway:
Target:
